---
ticker: "SURI"
name: "Simplify Propel Opportunities ETF"
url: "https://etf.net/etf/SURI"
grade: "F"
score: 15
graded_at: "2026-10-12"
category: "US Active Equity"
category_rank: "125 of 127"
methodology: "https://etf.net/methodology"
---

# SURI: Simplify Propel Opportunities ETF

Grade **F**, Score 15 of 100. Rank 125 of 127 in US Active Equity.

Graded Oct 12, 2026.

## Grade pillars

| Pillar | Score | Category rank |
| --- | --- | --- |
| Cost | 3 | 123 of 127 |
| Mission | Not scored | — |
| Risk | 17 | 117 of 126 |
| Tradability | 14 | 120 of 127 |
| Holdings | 28 | 113 of 124 |
| Durability | 61 | 53 of 127 |

## Top holdings

The fund holds 39 positions. These are the largest 30, by weight.

| # | Ticker | Name | Weight |
| --- | --- | --- | --- |
| 1 | PAGP | Plains Gp Hldgs L P | 45.11% |
| 2 | ACHV | Achieve Life Sciences Inc USD 0.001 | 8.72% |
| 3 | — | Achieve Life Sciences I Wts 30JUN30 | 5.20% |
| 4 | DCTH | Delcath Sys Inc USD 0.01 | 4.68% |
| 5 | — | Cash | 3.88% |
| 6 | MIST | Milestone Pharmaceuticals Inc Npv | 3.58% |
| 7 | CORT | Corcept Therapeutics Inc USD 0.001 | 3.30% |
| 8 | COLL | Collegium Pharmaceutical USD 0.001 | 2.73% |
| 9 | PHAT | Phathom Pharmaceuticals USD 0.0001 | 2.36% |
| 10 | ABEO | Abeona Therapeutics Inc USD 0.01 | 1.79% |
| 11 | AQST | Aquestive Therapeutics In USD 0.001 | 1.78% |
| 12 | OBIO | Orchestra Biomed Hldgs I USD 0.0001 | 1.72% |
| 13 | KYTX | Kyverna Therapeutics In USD 0.00001 | 1.50% |
| 14 | CMPS | Compass Pathways PLC USD 0.008 Adr | 1.38% |
| 15 | CABA | Cabaletta Bio Inc USD 0.00001 | 1.32% |
| 16 | IVA | Inventiva SA Npv Adr | 1.30% |
| 17 | LONA | Leonabio Inc USD 0.0001 | 1.22% |
| 18 | — | Achieve Life Sciences Wts | 1.16% |
| 19 | — | TELSAT 5.625 12/06/26 144A Corp | 1.09% |
| 20 | PROK | Prokidney Corp Del USD 0.0001 | 1.07% |
| 21 | PALI | Palisade Bio Inc USD 0.01 | 0.92% |
| 22 | ARTV | Artiva Biotherapeutics I USD 0.0001 | 0.91% |
| 23 | CLDX | Celldex Therapeutics Inc USD 0.001 | 0.84% |
| 24 | OCUL | Ocular Therapeutix Inc USD 0.0001 | 0.81% |
| 25 | — | Akero Therapeutics Inc Cvr | 0.57% |
| 26 | SABS | Sab Biotherapeutics Inc USD 0.0001 | 0.39% |
| 27 | CRVS | Corvus Pharmaceuticals I USD 0.0001 | 0.33% |
| 28 | IMUX | Immunic Inc USD 0.0001 | 0.32% |
| 29 | — | Contra Chinook Therape & Npv | <0.01% |
| 30 | EIGRQ | Eiger Biopharmaceuticals USD 0.0001 | <0.01% |

Source: etf.net, https://etf.net/etf/SURI. Please cite the page URL.